Suicidal ideations and suicide attempts after starting with aripiprazole, a new antipsychotic drug;Suïcidale ideaties en suïcidepogingen na instelling op aripiprazol, een nieuw antipsychoticum

Nederlands Tijdschrift voor Geneeskunde

Volumn 149, Issue 41, 2005, Pages 2296-2298

  Scholten, M R M ^a   Selten, J P ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; NEUROLEPTIC AGENT; OLANZAPINE;

ADULT; AGITATION; AKATHISIA; ARTICLE; CLINICAL ARTICLE; DISEASE SEVERITY; DRUG WITHDRAWAL; DYSPHORIA; FEMALE; HUMAN; INSOMNIA; MALE; PSYCHOSIS; SCHIZOPHRENIA; SUICIDAL BEHAVIOR; SUICIDE ATTEMPT;

ADULT; AKATHISIA, DRUG-INDUCED; ANTIPSYCHOTIC AGENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; PIPERAZINES; PSYCHOTIC DISORDERS; QUINOLONES; SUICIDE, ATTEMPTED; THINKING;

EID: 26844560070     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Marder SR, McQuade RD, Stock E, Kaplita S, Marcus R, Safferman AZ, et al. Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials. Schizophr Res. 2003;61:123-36.
2. Potkin SG, Saha AR, Kujawa MJ, Carson WH, Ali M, Stock E, et al. Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder. Arch Gen Psychiatry. 2003;60:681-90.
3. Palmer BA, Pankratz VS, Bostwick JM. The lifetime risk of suicide in schizophrenia: a reexamination. Arch Gen Psychiatry. 2005;62: 247-53.
4. Drake RE, Ehrlich J. Suicide attempts associated with akathisia. Am J Psychiatry. 1985;142:499-501.
5. Kasper S, Lerman MN, McQuade RD, Saha AR, Carson WH, Ali M, et al. Efficacy and safety of aripiprazole vs. haloperidol for long-term maintenance treatment following acute relapse of schizophrenia. Int J Neuropsychopharmacol. 2003;6:325-37.
6. El-Sayeh HG, Morganti C. Aripiprazole for schizophrenia [Cochrane review]. Cochrane Database Syst Rev. 2004;(2):CD004578.
7. Farde L, Nordstrom AL, Halldin C, Wiesel FA, Sedvall G. PET studies of dopamine receptors in relation to antipsychotic drug treatment. Clin Neuropharmacol. 1992;15(Suppl I Pt A):468A-9A.